Treatment of adenovirus infection or disease associated with adenovirus infection
AssigneeSymBio Pharmaceuticals Limited
InventorKoji FUKUSHIMA
Life of this patent
Estimating the term…
Abstract
[Problem] To provide a method for treatment of adenovirus infection or disease associated with adenovirus infection. [Solution] Provided is a pharmaceutical composition for treatment of adenovirus infection or disease associated with adenovirus infection, comprising brincidofovir, a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein the treatment comprises (i) intravenously administering, to a human subject, the brincidofovir, pharmaceutically acceptable salt thereof, or solvate thereof at 0.38 to 0.42 mg/kg twice weekly, or (ii) intravenously administering, to a human subject, the brincidofovir, pharmaceutically acceptable salt thereof, or solvate thereof at 18 to 22 mg/dose twice weekly.
Claims16
A pharmaceutical composition for treatment of an adenovirus infection or a disease associated with the adenovirus infection, comprising (i) intravenously administering, to a human subject, brincidofovir, a pharmaceutically acceptable salt thereof, or a solvate thereof at 0.38 to 0.42 mg/kg twice weekly, or (ii) intravenously administering, to the human subject, brincidofovir, the pharmaceutically acceptable salt thereof, or the solvate thereof at 18 to 22 mg/dose twice weekly.
Dependencies are inferred from the claim text.